Detalhe da pesquisa
1.
Secreted proteins MDK, WFDC2, and CXCL14 as candidate biomarkers for early diagnosis of lung adenocarcinoma.
BMC Cancer
; 23(1): 110, 2023 Jan 31.
Artigo
Inglês
| MEDLINE | ID: mdl-36721112
2.
Prediction of the VeriStrat test in first-line therapy of pemetrexed-based regimens for advanced lung adenocarcinoma patients.
Cancer Cell Int
; 20(1): 590, 2020 Dec 09.
Artigo
Inglês
| MEDLINE | ID: mdl-33298069
3.
Nomogram model for predicting cause-specific mortality in patients with stage I small-cell lung cancer: a competing risk analysis.
BMC Cancer
; 20(1): 793, 2020 Aug 24.
Artigo
Inglês
| MEDLINE | ID: mdl-32838776
4.
A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) database.
BMC Cancer
; 20(1): 666, 2020 Jul 17.
Artigo
Inglês
| MEDLINE | ID: mdl-32680464
5.
Survival difference between EGFR Del19 and L858R mutant advanced non-small cell lung cancer patients receiving gefitinib: a propensity score matching analysis.
Chin J Cancer Res
; 29(6): 553-560, 2017 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-29353978
6.
Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients.
Proc Natl Acad Sci U S A
; 110(52): 21083-8, 2013 Dec 24.
Artigo
Inglês
| MEDLINE | ID: mdl-24324171
7.
A phase I study of nimotuzumab plus docetaxel in chemotherapy-refractory/resistant patients with advanced non-small-cell lung cancer.
Chin J Cancer Res
; 28(1): 12-8, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-27041923
8.
[Prognostic factors and response of chemotherapy including amrubicin in small cell lung cancer patients].
Zhonghua Jie He He Hu Xi Za Zhi
; 38(4): 261-6, 2015 Apr.
Artigo
Chinês
| MEDLINE | ID: mdl-26268231
9.
[Prognosis related clinical and molecular factors in malignant pleural mesothelioma].
Zhonghua Jie He He Hu Xi Za Zhi
; 36(3): 162-8, 2013 Mar.
Artigo
Chinês
| MEDLINE | ID: mdl-23856136
10.
Analysis of spatial distribution characteristics and main influencing factors of heavy metals in road dust of Tianjin based on land use regression models.
Environ Sci Pollut Res Int
; 30(1): 837-848, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-35904743
11.
Characterization of Lung and Oral Microbiomes in Lung Cancer Patients Using Culturomics and 16S rRNA Gene Sequencing.
Microbiol Spectr
; 11(3): e0031423, 2023 06 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37092999
12.
EML4-ALK rearrangement and its clinical significance in Chinese patients with advanced non-small cell lung cancer.
Oncology
; 83(5): 248-56, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-22964709
13.
[Effect of pemetrexed plus platinum for chemotherapy-naive advanced non-small cell lung cancer].
Zhonghua Jie He He Hu Xi Za Zhi
; 35(2): 97-101, 2012 Feb.
Artigo
Chinês
| MEDLINE | ID: mdl-22455964
14.
[Correlation between the efficacy of epidermal growth factor receptor tyrosine kinase inhibitors and EGFR mutations in advanced squamous cell lung cancer].
Zhonghua Jie He He Hu Xi Za Zhi
; 35(5): 323-8, 2012 May.
Artigo
Chinês
| MEDLINE | ID: mdl-22883988
15.
Significant Upregulation of HERV-K (HML-2) Transcription Levels in Human Lung Cancer and Cancer Cells.
Front Microbiol
; 13: 850444, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35359739
16.
The prevalence and real-world therapeutic analysis of Chinese patients with KRAS-Mutant Non-Small Cell lung cancer.
Cancer Med
; 11(19): 3581-3592, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35394121
17.
A Novel Third-generation EGFR Tyrosine Kinase Inhibitor Abivertinib for EGFR T790M-mutant Non-Small Cell Lung Cancer: a Multicenter Phase I/II Study.
Clin Cancer Res
; 28(6): 1127-1135, 2022 03 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34740925
18.
Immediate Versus Delayed Treatment with EGFR Tyrosine Kinase Inhibitors after First-line Therapy in Advanced Non-small-cell Lung CANCER.
Chin J Cancer Res
; 23(2): 112-7, 2011 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-23483659
19.
Toripalimab in an advanced non-small cell lung cancer patient with poor general condition after multiline treatment: a case report.
J Int Med Res
; 49(10): 3000605211042988, 2021 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-34605304
20.
Efficacy and Safety of Combination Treatment With Apatinib and Osimertinib After Osimertinib Resistance in Epidermal Growth Factor Receptor-Mutant Non-small Cell Lung Carcinoma-A Retrospective Analysis of a Multicenter Clinical Study.
Front Mol Biosci
; 8: 639892, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34026823